Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.03 USD | -1.68% | -2.12% | -18.60% |
Financials (USD)
Sales 2024 * | 316M | Sales 2025 * | 406M | Capitalization | 1.13B |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -1M | EV / Sales 2024 * | 3.29 x |
Net cash position 2024 * | 93.72M | Net cash position 2025 * | 88.72M | EV / Sales 2025 * | 2.57 x |
P/E ratio 2024 * |
-18.1
x | P/E ratio 2025 * |
460
x | Employees | 278 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.51% |
Latest transcript on Mirum Pharmaceuticals, Inc.
1 day | -1.68% | ||
1 week | -2.12% | ||
1 month | -4.30% | ||
3 months | -16.30% | ||
6 months | -25.07% | ||
Current year | -18.60% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 45 | 18-05-06 | |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Peter Radovich
PSD | President | 46 | 20-04-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Walbert
BRD | Director/Board Member | 57 | 23-04-04 |
Michael Grey
FOU | Founder | 71 | 18-05-06 |
Patrick Heron
BRD | Director/Board Member | 53 | 18-11-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.02% | 1,487 M€ | +7.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 24.03 | -1.68% | 565,910 |
24-05-30 | 24.44 | +0.95% | 465,035 |
24-05-29 | 24.21 | -2.22% | 464,544 |
24-05-28 | 24.76 | +0.86% | 779,083 |
24-05-24 | 24.55 | -3.61% | 319,055 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.60% | 1.13B | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- MIRM Stock